NantHealth (NASDAQ:NH) Receives New Coverage From Analysts at StockNews.com
NantHealth (NASDAQ:NH) Receives New Coverage From Analysts at StockNews.com
StockNews.com began coverage on shares of NantHealth (NASDAQ:NH – Get Rating) in a report published on Saturday. The firm issued a hold rating on the stock.
StockNews.com 開始報道的股票 NantHealth（納斯達克股票代碼：NH — 獲取評級） 在週六發佈的一份報告中。該公司對該股發佈了持有評級。
NantHealth Stock Down 5.0 %
NanHealth 股票下跌 5.0%
Shares of NH opened at $1.51 on Friday. The company has a market cap of $11.63 million, a PE ratio of -0.20 and a beta of 1.83. The business has a fifty day moving average of $2.25 and a 200 day moving average of $1.96. NantHealth has a 52-week low of $1.24 and a 52-week high of $11.85.
NH的股票週五開盤價爲1.51美元。該公司的市值爲1163萬美元，市盈率爲-0.20，beta值爲1.83。該公司的五十天移動平均線爲2.25美元，200天移動平均線爲1.96美元。NantHealth創下52周低點1.24美元，創52周高點11.85美元。
Institutional Trading of NantHealth
nanHealth 的機構交易
A number of hedge funds and other institutional investors have recently bought and sold shares of NH. Goldman Sachs Group Inc. purchased a new position in shares of NantHealth during the second quarter valued at $36,000. Millennium Management LLC purchased a new position in shares of NantHealth during the second quarter valued at $110,000. Finally, Atria Wealth Solutions Inc. purchased a new position in shares of NantHealth during the first quarter valued at $170,000. Hedge funds and other institutional investors own 4.50% of the company's stock.
一些對沖基金和其他機構投資者最近買入和賣出了NH的股票。高盛集團公司在第二季度購買了NanThealth股票的新頭寸，價值36,000美元。千禧管理有限責任公司在第二季度收購了NanThealth股票的新頭寸，價值11萬美元。最後，Atria Wealth Solutions Inc.在第一季度購買了價值17萬美元的NantHealth股票的新頭寸。對沖基金和其他機構投資者擁有該公司4.50％的股票。
About NantHealth
關於 nanHealth
(Get Rating)
（獲取評分）
NantHealth, Inc is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer. The firm empowers treatment decisions, improves patient outcomes, validates treatment options, enables high-quality care, lowers costs, ensures appropriate reimbursement, and streamlines implementation and deployment.
NantHealth, Inc是一家基於證據的個性化醫療保健公司，致力於爲癌症等關鍵疾病提供治療。該公司支持治療決策，改善患者預後，驗證治療方案，提供高質量的護理，降低成本，確保適當的報銷，並簡化實施和部署。
Further Reading
進一步閱讀
- Get a free copy of the StockNews.com research report on NantHealth (NH)
- United Parcel Service Delivers A Warning To The Market
- Pulte Homes Is Hosting The Better, More Profitable Open House
- Virios Therapeutics Up 75% on Fibromyalgia Phase 3 Proposal
- A Top Is In For McDonald's Corporation Stock
- Strong Demand Makes Cleveland-Cliffs an Undervalued Mid-Cap
- 免費獲取 StockNews.com 關於 NantHealth（NH）的研究報告的副本
- 聯合包裹服務向市場發出警告
- Pulte Homes正在舉辦更好、更有利可圖的開放日
- Virios Therapeutics 因纖維肌痛第 3 階段提案上漲了 75%
- 麥當勞公司股票將達到頂峯
- 強勁的需求使克利夫蘭-克利夫斯成爲被低估的中型股
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.
接收 NanHealth Daily 的新聞和收視率 -在下面輸入您的電子郵件地址，通過Marketbeat.com的免費每日電子郵件時事通訊接收NantHealth及相關公司最新新聞和分析師評級的簡明每日摘要。